Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Impact on survival of early tumor growth between surgery and radiotherapy in patients with de novo glioblastoma.

De Barros A, Attal J, Roques M, Nicolau J, Sol JC, Cohen-Jonathan-Moyal E, Roux FE.

J Neurooncol. 2019 May;142(3):489-497. doi: 10.1007/s11060-019-03120-3. Epub 2019 Feb 19.

PMID:
30783874
2.

Early tumor growth between initial resection and radiotherapy of glioblastoma: incidence and impact on clinical outcomes.

Villanueva-Meyer JE, Han SJ, Cha S, Butowski NA.

J Neurooncol. 2017 Aug;134(1):213-219. doi: 10.1007/s11060-017-2511-z. Epub 2017 May 31.

3.

Long-term follow-up results of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastoma multiforme patients. The importance of MRI information in survival: Single-center experience.

Lukács G, Tóth Z, Sipos D, Csima M, Hadjiev J, Bajzik G, Cselik Z, Semjén D, Repa I, Kovács Á.

Ideggyogy Sz. 2018 Mar 30;71(3-04):95-103. doi: 10.18071/isz.71.0095.

PMID:
29889468
4.

Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide.

Donato V, Papaleo A, Castrichino A, Banelli E, Giangaspero F, Salvati M, Delfini R.

Tumori. 2007 May-Jun;93(3):248-56.

PMID:
17679459
5.

Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.

Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD.

J Neurosurg. 2015 Apr;122(4):757-65. doi: 10.3171/2014.11.JNS13295. Epub 2015 Jan 16.

PMID:
25594327
6.

Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.

Birol Sarica F, Tufan K, Cekinmez M, Sen O, Cem Onal H, Mertsoylu H, Topkan E, Pehlivan B, Erdogan B, Nur Altinors M.

J Neurosurg Sci. 2010 Mar;54(1):7-19.

PMID:
20436394
7.

Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.

Piroth MD, Holy R, Pinkawa M, Stoffels G, Kaiser HJ, Galldiks N, Herzog H, Coenen HH, Eble MJ, Langen KJ.

Radiother Oncol. 2011 May;99(2):218-24. doi: 10.1016/j.radonc.2011.03.006. Epub 2011 Apr 16.

PMID:
21497925
8.

Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.

Fujii Y, Muragaki Y, Maruyama T, Nitta M, Saito T, Ikuta S, Iseki H, Hongo K, Kawamata T.

J Neurosurg. 2018 Jul;129(1):1-9. doi: 10.3171/2017.3.JNS162383. Epub 2017 Sep 8.

PMID:
28885120
9.

Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma.

Pirzkall A, McGue C, Saraswathy S, Cha S, Liu R, Vandenberg S, Lamborn KR, Berger MS, Chang SM, Nelson SJ.

Neuro Oncol. 2009 Dec;11(6):842-52. doi: 10.1215/15228517-2009-005.

10.

The Prognostic Impact of Ventricular Opening in Glioblastoma Surgery: A Retrospective Single Center Analysis.

Behling F, Kaltenstadler M, Noell S, Schittenhelm J, Bender B, Eckert F, Tabatabai G, Tatagiba M, Skardelly M.

World Neurosurg. 2017 Oct;106:615-624. doi: 10.1016/j.wneu.2017.07.034. Epub 2017 Jul 18.

PMID:
28729143
11.

Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.

Grossman R, Shimony N, Shir D, Gonen T, Sitt R, Kimchi TJ, Harosh CB, Ram Z.

Ann Surg Oncol. 2017 Mar;24(3):794-800. doi: 10.1245/s10434-016-5635-z. Epub 2016 Oct 20.

PMID:
27766560
12.

Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.

Seidlitz A, Siepmann T, Löck S, Juratli T, Baumann M, Krause M.

Radiat Oncol. 2015 Aug 16;10:172. doi: 10.1186/s13014-015-0478-5.

13.

Impact of removed tumor volume and location on patient outcome in glioblastoma.

Awad AW, Karsy M, Sanai N, Spetzler R, Zhang Y, Xu Y, Mahan MA.

J Neurooncol. 2017 Oct;135(1):161-171. doi: 10.1007/s11060-017-2562-1. Epub 2017 Jul 6.

PMID:
28685405
14.

Huge heterogeneity in survival in a subset of adult patients with resected, wild-type isocitrate dehydrogenase status, WHO grade II astrocytomas.

Poulen G, Gozé C, Rigau V, Duffau H.

J Neurosurg. 2018 Apr 20:1-10. doi: 10.3171/2017.10.JNS171825. [Epub ahead of print]

PMID:
29676695
15.

An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.

Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1438-43.

PMID:
16029805
16.

A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.

Konar SK, Bir SC, Maiti TK, Nanda A.

J Neurosurg Pediatr. 2017 Feb;19(2):239-248. doi: 10.3171/2016.8.PEDS1631. Epub 2016 Nov 4. Review.

PMID:
27813458
17.

Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.

Grabowski MM, Recinos PF, Nowacki AS, Schroeder JL, Angelov L, Barnett GH, Vogelbaum MA.

J Neurosurg. 2014 Nov;121(5):1115-23. doi: 10.3171/2014.7.JNS132449. Epub 2014 Sep 5.

PMID:
25192475
18.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
19.

Prognostic factors effective on survival of patients with glioblastoma: Anadolu Medical Center experience.

Guden M, Ayata HB, Ceylan C, Kilic A, Engin K.

Indian J Cancer. 2016 Jul-Sep;53(3):382-386. doi: 10.4103/0019-509X.200664.

20.

Leptomeningeal enhancement on preoperative brain MRI in patients with glioblastoma and its clinical impact.

Kim H, Lim DH, Kim TG, Lee JI, Nam DH, Seol HJ, Kong DS, Choi JW, Suh YL, Kim ST.

Asia Pac J Clin Oncol. 2018 Oct;14(5):e366-e373. doi: 10.1111/ajco.12861. Epub 2018 Feb 23.

PMID:
29473335

Supplemental Content

Support Center